Challenges and strategies for ocular posterior diseases therapy via non-invasive advanced drug delivery

被引:22
|
作者
Qi, Qi [1 ]
Wei, Yidan [1 ]
Zhang, Xin [1 ]
Guan, Jian [1 ]
Mao, Shirui [1 ]
机构
[1] Shenyang Pharmaceut Univ, Sch Pharm, 103 Wenhua Rd, Shenyang 110016, Peoples R China
关键词
Ocular posterior segment; Non-invasive; Topical drug delivery; Nanocarriers; NANOSTRUCTURED LIPID CARRIERS; RETINAL-PIGMENT EPITHELIUM; CONTACT-LENSES; TRIAMCINOLONE ACETONIDE; PHYSIOLOGICAL BARRIERS; POLYMERIC MICELLES; TEAR FILM; NANOPARTICLES; EYE; SEGMENT;
D O I
10.1016/j.jconrel.2023.07.055
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Posterior segment diseases, such as age-related macular degeneration (AMD) and diabetic retinopathy (DR) are vital factor that seriously threatens human vision health and quality of life, the treatment of which poses a great challenge to ophthalmologists and ophthalmic scientists. In particular, ocular posterior drug delivery in a noninvasive manner is highly desired but still faces many difficulties such as rapid drug clearance, limited permeability and low drug accumulation at the target site. At present, many novel non-invasive topical ocular drug delivery systems are under development aiming to improve drug delivery efficiency and biocompatibility for better therapy of posterior segment oculopathy. The purpose of this review is to present the challenges in the noninvasive treatment of posterior segment diseases, and to propose strategies to tackle these bottlenecks. First of all, barriers to ocular administration were introduced based on ocular physiological structure and behavior, including analysis and discussion on the influence of ocular structures on noninvasive posterior segment delivery. Thereafter, various routes of posterior drug delivery, both invasive and noninvasive, were illustrated, along with the respective anatomical obstacles that need to be overcome. The widespread and risky application of invasive drug delivery, and the need to develop non-invasive local drug delivery with alternative to injectable therapy were described. Absorption routes through topical administration and strategies to enhance ocular posterior drug delivery were then discussed. As a follow-up, an up-to-date research advances in non-invasive delivery systems for the therapy of ocular fundus lesions were presented, including different nanocarriers, contact lenses, and several other carriers. In conclusion, it seems feasible and promising to treat posterior oculopathy via non-invasive local preparations or in combination with appropriate devices.
引用
收藏
页码:191 / 211
页数:21
相关论文
共 50 条
  • [11] Ocular Drug Delivery - New Strategies for Targeting Anterior and Posterior Segments of the Eye
    Fangueiro, Joana F.
    Veiga, Francisco
    Silva, Amelia M.
    Souto, Eliana B.
    CURRENT PHARMACEUTICAL DESIGN, 2016, 22 (09) : 1135 - 1146
  • [12] A non-invasive nanoparticle-based sustained dual-drug delivery system as an eyedrop for endophthalmitis
    Mahaling, Binapani
    Baruah, Namrata
    Ahamad, Nadim
    Maisha, Nuzhat
    Lavik, Erin
    Katti, Dhirendra S.
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2021, 606
  • [13] Novel Non-Invasive Protein and Peptide Drug Delivery Approaches
    Wallis, L.
    Kleynhans, E.
    Du Toit, T.
    Gouws, C.
    Steyn, D.
    Steenekamp, J.
    Viljoen, J.
    Hamman, J.
    PROTEIN AND PEPTIDE LETTERS, 2014, 21 (11) : 1087 - 1101
  • [14] Advances in non-invasive drug delivery for atherosclerotic heart disease
    Maranhao, Raul C.
    Tavares, Elaine R.
    EXPERT OPINION ON DRUG DELIVERY, 2015, 12 (07) : 1135 - 1147
  • [15] A Review of Non-Invasive Drug Delivery through Respiratory Routes
    Zhang, Yong-Bo
    Xu, Dong
    Bai, Lu
    Zhou, Yan-Ming
    Zhang, Han
    Cui, Yuan-Lu
    PHARMACEUTICS, 2022, 14 (09)
  • [16] Non-invasive systemic drug delivery through mucosal routes
    Goyal, Amit K.
    Singh, Ranjit
    Chauhan, Gaurav
    Rath, Goutam
    ARTIFICIAL CELLS NANOMEDICINE AND BIOTECHNOLOGY, 2018, 46 : 539 - 551
  • [17] Nano-based ocular drug delivery systems: an insight into the preclinical/clinical studies and their potential in the treatment of posterior ocular diseases
    Su, Yun
    Fan, Xianqun
    Pang, Yan
    BIOMATERIALS SCIENCE, 2023, 11 (13) : 4490 - 4507
  • [18] Current non-invasive strategies for brain drug delivery: overcoming blood-brain barrier transport
    Zheng, Xiaoxiao
    Yang, Jingyao
    Hou, Yiwei
    Fang, Yong
    Wu, Kaiyu
    Song, Yanna
    Liu, Kangding
    Zhu, Jie
    MOLECULAR BIOLOGY REPORTS, 2024, 51 (01)
  • [19] Nanocarrier functionalization strategies for targeted drug delivery in skin cancer therapy: current progress and upcoming challenges
    Di Filippo, Leonardo Delello
    de Paula, Mariana Carlomagno
    Duarte, Jonatas Lobato
    de Paula, Geanne Aparecida
    Frigieri, Isadora
    Chorilli, Marlus
    EXPERT OPINION ON DRUG DELIVERY, 2023, 20 (06) : 831 - 849
  • [20] Advanced Technologies of Drug Delivery to the Posterior Eye Segment Targeting Angiogenesis and Ocular Cancer
    Ansari, Mudassir
    Kulkarni, Yogesh A.
    Singh, Kavita
    CRITICAL REVIEWS IN THERAPEUTIC DRUG CARRIER SYSTEMS, 2024, 41 (01): : 85 - 124